Just diagnosed with GM1 gangliosidosis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees GM1 gangliosidosis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive GM1 gangliosidosis hub →Overview
GM1 gangliosidosis is a rare condition. Also known as Beta-galactosidase-1 deficiency, GLB1 deficiency, Landing disease. Tomeko brings together the specialists, research, clinical trials, treatments and community for GM1 gangliosidosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:354 · OMIM 230500, 230600, 230650 · ICD-10 E75.1 · GARD 0010891
Find care for GM1 gangliosidosis
Authoritative references for GM1 gangliosidosis
Research & market landscape for GM1 gangliosidosis
Following GM1 gangliosidosis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for GM1 gangliosidosis — the real-world landscape behind the condition, in one place.
- Latest GM1 gangliosidosis research on PubMed ↗
- Recruiting GM1 gangliosidosis trials on ClinicalTrials.gov ↗
- Explore the GM1 gangliosidosis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for GM1 gangliosidosis and every rare condition. See how Tomeko works with industry →
Common questions
What is GM1 gangliosidosis?
GM1 gangliosidosis is a rare condition. Also known as Beta-galactosidase-1 deficiency, GLB1 deficiency, Landing disease. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for GM1 gangliosidosis together in one place.
What are the symptoms of GM1 gangliosidosis?
Symptoms of GM1 gangliosidosis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats GM1 gangliosidosis.
How is GM1 gangliosidosis treated?
Treatment for GM1 gangliosidosis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see GM1 gangliosidosis, and review current options with them.
What causes GM1 gangliosidosis — is it genetic?
The cause and inheritance of GM1 gangliosidosis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats GM1 gangliosidosis can explain what it means for you and your family.
I was just diagnosed with GM1 gangliosidosis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees GM1 gangliosidosis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for GM1 gangliosidosis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat GM1 gangliosidosis, filtered to your area.
Are there clinical trials for GM1 gangliosidosis?
Tomeko shows live, recruiting studies for GM1 gangliosidosis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3
